Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Bormann-kennedy Barbara-jean Anne
Over the trailing 90 days, Bormann-kennedy Barbara-jean Anne (Director at Xeris Biopharma Holdings, Inc.) traded $300K of stock (net buying $105K) in XERS, per 3 SEC Form 4 transactions.
- Role
- Director
- Companies
- XERS
- Window
- Trailing 90 days · 3 transactions · CIK 1635065
- Net activity
- +$105K ($203K bought · $98K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | 3 | $203K | $98K | $105K |
Transactions (3)
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Bormann-kennedy's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.